Showing results (1-10 of 306) with videos related to
Sort By:
Pageof 31
American Journal of Hematology|October 2, 2019
Preventing infectious complications when treating non-malignant immune-mediated hematologic disordersLuis Malpica, David van Duin, Stephan MollHematology. American Society of Hematology. Education Program|December 4, 2020
Practical approach to monitoring and prevention of infectious complications associated with systemic corticosteroids, antimetabolites, cyclosporine, and cyclophosphamide in nonmalignant hematologic diseasesLuis Malpica, Stephan MollClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 22, 2011
Diagnostic challenges and opportunities in older adults with infectious diseasesDavid van DuinJournal of Clinical Microbiology|July 24, 2015
Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae: Are We at the End of the Road?David van Duin, Yohei DoiClinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 21, 2022
An overview of COVID-19 in solid organ transplantationLuther Bartelt, David van DuinDrugs|March 18, 2017
Novel Beta-Lactamase Inhibitors: Unlocking Their Potential in TherapyDarren Wong, David van DuinVirulence|September 6, 2016
The global epidemiology of carbapenemase-producing EnterobacteriaceaeDavid van Duin, Yohei DoiEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 25, 2021
Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directionsKathleen Tompkins, David van DuinCurrent Opinion in Organ Transplantation|June 7, 2019
Carbapenemase-producing organisms in solid organ transplantationDarren Wong, David van DuinCleveland Clinic Journal of Medicine|April 3, 2013
Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsFederico Perez, David Van DuinPageof 31